PPLI vs VUL: What Separates Private Placement from Retail Variable Universal Life

Both products are variable life insurance contracts. Both hold their investments in a separate account, both are governed by IRC Section 7702, both must satisfy the diversification test of Section 817(h), and both pay a death benefit that is generally excluded from the beneficiary's income under Section 101(a). Where they part company is not the tax code. It is the securities law under which the contract is offered, and everything that follows from it: who may buy, what the separate account may hold, who decides what it holds, and how much of the premium is consumed by the machinery of distribution.

Is PPLI a type of VUL?

Yes, in almost every case. A private placement policy is typically a variable universal life contract, with flexible premium, an adjustable death benefit and cash value held in a separate account whose performance the policyholder bears. Practitioners sometimes call PPLI "institutional VUL," which is closer to the truth than treating the two as rivals. The words "private placement" describe how the contract is sold, not what it is.

The distinction that matters is registration. A retail VUL policy is a registered security. The contract is registered with the SEC, the buyer receives a prospectus, and the subaccounts are registered investment companies under the Investment Company Act of 1940. A private placement policy is offered under the exemptions of Regulation D, which removes the prospectus requirement and, more importantly, removes the constraint that the separate account may only hold registered funds.

PPLI vs VUL: the comparison in one table

	Retail VUL	PPLI
Legal form	Variable universal life	Variable universal life
How it is offered	Registered with the SEC; prospectus delivered	Private placement under Regulation D; offering memorandum
Who may buy	Any suitable purchaser	Accredited investors; in practice qualified purchasers, because the underlying funds usually rely on Section 3(c)(7)
Investment menu	A carrier-selected list of registered fund subaccounts, commonly 30 to 100	Insurance-dedicated funds and insurance-dedicated separately managed accounts holding hedge, private credit, private equity and other unregistered strategies
Who selects the investments	The policyholder allocates freely among the listed subaccounts	The policyholder sets the mandate; a discretionary manager makes the decisions
Section 817(h) diversification	Applies; satisfied by looking through to the registered funds	Applies; tested quarterly on a bespoke portfolio, and monitored deliberately
Investor control exposure	Low. Allocating among subaccounts that are not publicly available sits on ruled-on ground	Real, and managed. Bespoke mandates sit closer to the line, which is why documentation and conduct matter
Death benefit design	Often maximized; the coverage is part of what is being bought	Minimized to the Section 7702 corridor, to reduce the mortality drag on the investment
Typical scale	No practical floor	Carrier minimums in the millions, funded over several years to stay outside MEC treatment
Cost structure	Commission-led, embedded in policy charges	Negotiated and disclosed; no first-year commission load in the retail sense
Surrender charges	Common, and can run a decade or more	Often absent, or limited to the first few years
Underwriting	Full medical underwriting	Often simplified or guaranteed issue, because the mortality risk is small relative to the premium
Usual owner	The insured, or a straightforward ILIT	An irrevocable or dynasty trust, integrated with the family's wider planning

Who may buy each

Retail VUL is available to anyone who can pass underwriting and meet the suitability standards of the selling broker-dealer. There is no wealth test.

PPLI has two gates, and they are routinely confused with each other. The first is accredited investor status under 17 C.F.R. § 230.501: net worth above $1 million excluding the primary residence, or income above $200,000 individually or $300,000 jointly in each of the two most recent years. Since 2020 the definition also reaches certain licensed professionals and knowledgeable employees of the issuing fund, which occasionally matters for fund principals buying policies of their own.

The second gate is the one that usually binds. Insurance-dedicated funds are commonly structured to rely on the exclusion in Investment Company Act § 3(c)(7), and every investor in a § 3(c)(7) vehicle must be a qualified purchaser, which for a natural person means not less than $5 million in investments under § 2(a)(51). So a buyer can be comfortably accredited and still be unable to reach the funds that make the policy worth owning. Neither test says anything about whether the structure is a good idea; both are eligibility, not suitability. We separate the two, along with carrier minimums and the economics, in PPLI minimum investment and eligibility.

What the separate account can hold

A retail VUL menu is a list of registered funds with daily pricing, daily liquidity and standardized fee disclosure. That is a genuine consumer protection and a genuine constraint. It excludes, by construction, the strategies that generate the tax drag PPLI is usually bought to solve: high-turnover hedge strategies, private credit, direct lending, private equity and venture.

Private placement policies reach those strategies through insurance-dedicated funds, pooled vehicles available only to insurance company separate accounts and never to an individual investor directly, and through insurance-dedicated separately managed accounts run by a discretionary manager on the carrier's platform. The exclusivity is not a marketing artifact. It is a condition of the tax treatment: a fund the policyholder could also buy personally is exactly the fact pattern that Rev. Rul. 2003-92 treats as making the policyholder the owner of the underlying assets.

Both products face the same diversification test. Section 817(h) and Treas. Reg. § 1.817-5 require that no more than 55% of the account's value sit in any one investment, 70% in any two, 80% in any three and 90% in any four, tested quarterly. A retail policy satisfies this almost incidentally by looking through to registered funds. A private placement policy satisfies it by design and monitoring, and a concentrated position, whether a founder's stock or a single fund, is the usual reason a proposed structure fails before it starts.

Who gets to choose the investments

This is the trade at the center of the comparison, and the one most often glossed over in a sales conversation. A retail VUL owner may move money among the listed subaccounts whenever they like. A PPLI owner may not do the equivalent. The policyholder sets the mandate, meaning asset classes, risk parameters and style, and a discretionary manager decides what the account actually buys and sells.

The restriction is not a carrier preference. It is the investor control doctrine, and a policyholder who ignores it is treated as the owner of the assets and taxed on the account's income currently, which removes the entire point of the structure. Webber v. Commissioner, 144 T.C. 324 (2015), turned on a taxpayer whose "recommendations" were followed without exception; the court looked at conduct, not paperwork. What a policyholder may and may not do is set out in full in the investor control doctrine.

For a family accustomed to running its own book, this is a real concession. It is also the most common reason a well-qualified family decides against PPLI, and there is nothing wrong with that decision.

Where the cost difference actually sits

Retail VUL is distributed by licensed agents and broker-dealers, and the compensation is substantial and front-loaded. That cost does not appear as a line item; it is recovered through mortality and expense charges, premium loads, administrative fees and surrender charges that persist for years. Private placement policies are placed through specialist intermediaries on negotiated terms. Compensation still exists, and the claim that PPLI carries no distribution cost is marketing rather than fact. But it is disclosed, it is not a first-year commission of the retail kind, and on a large case it is negotiable.

Two further differences compound the gap. Mortality charges are far lower in a private placement policy because the death benefit is deliberately held near the statutory corridor rather than sold at a multiple of cash value. And the underlying investment expense is institutional rather than retail. The all-in figures, what they include, and the point at which the arithmetic stops working are set out in PPLI costs and economics; quoting ranges here would only invite the comparison to be made on the wrong basis.

Tax treatment: identical framework, different outcome

Nothing in the Internal Revenue Code treats a private placement policy more favorably than a registered one. Both defer tax on inside buildup while the contract remains in force. Both pay a death benefit that is generally excluded from the beneficiary's gross income under Section 101(a). Both are subject to the modified endowment contract rules of Section 7702A, and both, if they avoid MEC status, allow the owner to withdraw to basis and borrow beyond it without a current income tax charge under Section 72(e).

Those loans deserve a plainer description than they usually get. A policy loan is not tax-free money. It is untaxed borrowing that depends on the contract staying in force. If the policy lapses or is surrendered with a loan outstanding, the gain becomes taxable in that year, and the taxpayer can face a bill with no asset left to pay it from. That risk exists identically in both products. It is simply larger in a policy holding eight figures.

The outcomes differ because the inputs differ. A wrapper that costs 200 basis points and holds registered funds is a weaker vehicle than one that costs materially less and holds the strategies that were generating the tax drag in the first place. That is an arithmetic difference, not a legal one, and it should be modeled on the family's actual portfolio rather than assumed. The mechanics of the tax treatment itself are set out in PPLI tax benefits.

How family offices use each

In a family office, retail VUL rarely appears as an investment vehicle. Where it appears at all, it is doing insurance work: key-person coverage, funding a buy-sell agreement, a policy on a family member whose death would create a liquidity problem.

PPLI appears on the other side of the balance sheet, as an asset-location decision. The alternatives sleeve, the part of the portfolio throwing off ordinary income and short-term gain, is moved inside a policy owned by an irrevocable trust, while the tax-efficient equity sleeve stays outside where its long-term gains and step-up are already efficient. That framing, rather than "should we buy insurance," is how the decision is usually taken, and it is developed further in the chief investment officer's guide to PPLI.

When retail VUL is the better answer

It happens more often than the private placement market likes to say, and there are four recognizable cases.

The first is when the death benefit is the point. If a family needs coverage rather than a wrapper, the whole design logic of PPLI, which is to suppress the death benefit and minimize mortality cost, runs against the objective.

The second is scale. Below carrier minimums, the fixed costs of a private placement structure, meaning counsel, trust drafting, ongoing compliance and quarterly diversification testing, are spread across too little premium to earn their keep. A registered policy carries a worse ongoing rate on a much smaller absolute base.

The third is temperament. A family that wants to decide, personally and repeatedly, what the money is invested in should not buy a structure whose tax treatment depends on not doing that.

The fourth is the shape of the portfolio. If the assets going inside are low-turnover index exposure or municipal bonds, there is very little tax drag to eliminate, and the wrapper's cost is being paid for a benefit that barely exists. We set out the full screen in who PPLI may suit, and who it may not.

The bottom line

PPLI and retail VUL are the institutional and retail ends of one contract. The tax treatment is the same; the buyer, the investment menu, the cost base and the degree of control are not. PPLI wins where a large, long-horizon, tax-inefficient portfolio can absorb the fixed costs and the family can live with discretionary management. Retail VUL wins where coverage is the objective, the premium is modest, or the owner wants to keep their hands on the wheel. The comparison is decided by the facts of the portfolio, not by which product is more sophisticated.

---

PPLI.com provides independent intelligence on Private Placement Life Insurance for qualified families and their advisors. For a confidential consultation, visit ppli.com/private-consultation.

Sources and authorities

The statements above rest on the following primary sources, and describe United States federal law as it stood at the date of last review. Nothing here is advice on any particular set of facts.

• 26 U.S.C. § 7702 and § 7702A. The definition of a life insurance contract, and the modified endowment contract rules that govern how quickly a policy may be funded. Both apply identically to registered and private placement contracts.
• 26 U.S.C. § 817(h) with 26 C.F.R. § 1.817-5. The diversification requirement, including the 55/70/80/90 percentages at § 1.817-5(b)(1) and the definition of an insurance dedicated fund at § 1.817-5(f)(2)(i).
• 26 U.S.C. § 101(a) and § 72(e). The exclusion of death benefits from gross income, and the treatment of amounts received under a contract during the insured's lifetime.
• 17 C.F.R. § 230.501 and § 230.506. The accredited investor definition and the Regulation D exemptions under which private placement policies are offered.
• Investment Company Act § 2(a)(51) and § 3(c)(7). The qualified purchaser definition and the exclusion on which insurance dedicated funds commonly rely.
• Rev. Rul. 2003-91 and Rev. Rul. 2003-92, with Webber v. Commissioner, 144 T.C. 324 (2015). The investor control authorities that constrain what a policyholder of either product may direct.
• US Senate Committee on Finance, Private Placement Life Insurance: A Tax Shelter for the Ultra-Wealthy Masquerading as Insurance, 21 February 2024. Carrier data on the size and shape of the US private placement market, compelled from seven providers.

Last reviewed 31 August 2026. This article is educational and is not legal, tax or insurance advice. See our editorial standards for how we source and correct this material.